NCT04905329 (Def_Special) is a clinical trial of Empegfilgrastim in Solid Tumor, sponsored by Moscow Clinical Scientific Center.

Who is sponsoring NCT04905329?

NCT04905329 is sponsored by Moscow Clinical Scientific Center.

What drugs are being tested in NCT04905329?

Interventions in NCT04905329: Empegfilgrastim.

What condition does NCT04905329 study?

NCT04905329 studies Solid Tumor, High-Risk Cancer, Breast Cancer, Gastrointestinal Cancer, Gynecological Malignancies, Myelosuppression.

Is NCT04905329 still recruiting?

NCT04905329 is currently status unknown. Last updated 2 June 2021.

Last reviewed 2021-06-02 · How we verify

NCT04905329: Def_Special

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Multicenter Prospective Post-registration Study of Empegfilgrastim to Evaluate Safety and Efficacy in Special Cancer Populations

Status unknown Last updated 2 June 2021

What this trial tests

trial testing Empegfilgrastim in Solid Tumor in 285 participants. Status unknown.

Timeline

28 April 2020

Primary endpoint
31 December 2022

1 September 2023

Quick facts

Lead sponsor	Moscow Clinical Scientific Center
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	285
Start date	28 April 2020
Primary completion	31 December 2022
Estimated completion	1 September 2023
Sites	3 locations across Russia

Drugs / interventions tested

Empegfilgrastim — full drug profile →

Conditions studied

Solid Tumor — all drugs for Solid Tumor →
High-Risk Cancer — all drugs for High-Risk Cancer →
Breast Cancer — all drugs for Breast Cancer →
Gastrointestinal Cancer — all drugs for Gastrointestinal Cancer →

Sponsor

Moscow Clinical Scientific Center

Who can join

Adults 18 to 80, any sex, with Solid Tumor or High-Risk Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was designed to evaluate the efficacy and safety of Extimia® (INN - empegfilgrastim) in reducing the frequency, duration of neutropenia, the incidence of febrile neutropenia and infections caused by febrile neutropenia in patients with High and "Gray Zone" Risk Reccurrence Breast Cancer, Gastointestinal Cancers and Gynecological Malignancies

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Empegfilgrastim

Trials testing the same drug.

NCT04811443 — DEFENDOR: A Multicenter Prospective Observational Post-registration stuDy of Extimia® (INN: empEgfilrastim) to Evaluate · unknown

Other recruiting trials for Solid Tumor

Currently open trials in the same condition.

NCT07489378 — NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rar · recruiting
NCT07487597 — Functionally Enhanced ALPP-Targeted Engineered T Cells in Advanced Solid Tumors · EARLY_PHASE1 · recruiting
NCT07382544 — Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss · Phase 1 · recruiting
NCT07466160 — A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors · Phase 1, PHASE2 · recruiting
NCT07450560 — Research on Real-time Proton Therapy Guidance Through Monitoring Proton Range Using All-digital PET · active not recruiting

Other Moscow Clinical Scientific Center trials

Trials by the same sponsor.

NCT05775107 — Pancreatic Fibrosis as a Prognostic Factor · unknown
NCT05775120 — Epidemiology of Helicobacter Pylori Infection in Moscow · unknown
NCT04800393 — The Impact of Inhalation vs Total Intravenous Anesthesia on the Immune Status and Mortality in Patients Undergoing Breas · NA · recruiting
NCT03683537 — Association Between Changes of GFAP After Surgery and Postoperative Delayed Cognitive Recovery · completed
NCT04815733 — Pressure Support Ventilation During Laparoscopic and Abdominal Robotic Surgery. · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04905329 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Moscow Clinical Scientific Center
Last refreshed: 2 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04905329.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing